On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.

Zacks Maintains Strong $4.44 Price Target for Pressure BioSciences Inc. (PBIO)

  • Zacks has reiterated support for their initial $4.44 share price target for Pressure BioSciences
  • PBIO’s fundamentals remain strong, with record sales of consumables and increased revenue from products and services over same quarter previous year
  • Company anticipates doubling of total revenue in 2020, driven by anticipated sales of their proprietary BaroShear K45 System, which provides the CBD market with much-needed, superior water-soluble nanoemulsions of CBD Oil

Zacks Small Cap Research, a division of Zacks Investment Research, has announced that they are maintaining their strong $4.44 share price target originally stated in their initial coverage of Pressure BioSciences Inc. (OTCQB: PBIO), a leader in the sale and development of pressure-based consumables, instruments, and platform technology solutions to the global life sciences industry. PBIO’S unique and enabling pressure platform technologies can be used in many large and growing markets (e.g., food preservation, medical/lab applications, and, importantly, CBD oil water solubility).

The Zacks report (http://nnw.fm/4RMgj) points to demand that “is expected to accelerate starting in 2020,” which nonetheless follows many years of consistent yearly revenue increases by PBIO. The company itself is standing by its stated anticipation of doubling revenue in 2020, due to expected sales of their soon-to-be-released $200,000 BaroShear K45 systems. These new instrument systems utilize PBI’s proprietary Ultra Shear Technology™ (UST) platform to effectively produce high quality, long-term stable, water-soluble nanoemulsions of CBD Oil (http://nnw.fm/F9flN).

True water-soluble CBD is now seen as critical to the CBD market, since water-solubility is necessary for bioavailability. It also allows for accurate dosing for consumers, something that has been sorely missing up to now. Without accurate dosing, you can’t really control the amount of CBD that actually gets into the bloodstream and available by the consumer. In essence, it doesn’t matter how organic or potent a company says their CBD is, if it is not truly water soluble then it is not going to be properly absorbed by the body and will be largely excreted. PBIO’s revolutionary, patented, and highly anticipated UST-based BaroShear K45 system is expected to provide superior water-solubility, long-term shelf stability, improved safety, and significantly increased bio-availability compared to current nanoemulsification methods, overcoming key weaknesses of the other approaches.

The BaroShear K45 features a unique, highly efficient, customized ultra-high pressure (UHP) subsystem generating pressure levels of up to 45,000 psi. The system’s maximum throughput capacity is one liter per eight hours. The platform is also suitable for processing small volumes (e. g., min. 20 ml) of high-quality CBD oil into a water-soluble nanoemulsion with minimal production loss.

To view the full Zacks report, visit http://nnw.fm/4RMgj

For more information, visit the company’s website at www.PressureBioSciences.com

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://nnw.fm/PBIO

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.networknewswire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.networknewswire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Archives

Select A Month

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217